Research has identified an immunoevasive phenotype in certain human cancers characterized by elevated NRF2 activity, which correlates with reduced IFNγ levels, diminished HLA-I expression, and decreased infiltration of T cells and macrophages in squamous cell carcinomas of the lung, head and neck, cervix, and esophagus. The gene discussed is NFE2L2; the disease is cancer.